Clinical trial
Combination Chemotherapy in Patients With Zollinger-Ellison Syndrome and Tumors…
NCT00001165 · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH · Completed
Key facts
| NCT number | NCT00001165 |
|---|---|
| Title | Combination Chemotherapy in Patients With Zollinger-Ellison Syndrome and Tumors of the Pancreas |
| Official title | Evaluation of Chemotherapy With Streptozotocin Combined With 5-Fluorouracil and Adriamycin in Patients With Zollinger-Ellison Syndrome and Metastatic Non-Beta-Islet Cell Neoplasm |
| Lead sponsor | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Islet Cell Adenoma, Neoplasm Metastasis, Zollinger Ellison Syndrome |
| Intervention type | Drug |
| Interventions | combined chemotherapy with streptozotocin, 5-fluorouracil, and doxorubicin |
| Enrollment | 999 |
| Start date | Sep 1, 1978 |
| Completion | Aug 1, 2003 |
| First posted | Nov 4, 1999 |
| Last update posted | Mar 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: